跳至主要内容
临床试验/NCT03323112
NCT03323112招募中不适用

Immune Responses to Influenza Vaccinations and Viruses Among Health Care Personnel

Finnish Institute for Health and Welfare1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年10月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
1
主要终点
Humoral immunity against each present season's vaccine and circulating influenza strains

研究概览

简要总结

This is an investigator-initiated 10 year long open cohort observational study, aiming to increase the understanding of the humoral and cellular immunological mechanisms of vaccination against influenza, including effects of repeated vaccination, the duration of protection, immunity against circulating viruses, as well as factors affecting the immunological responses and immunity against other vaccine preventable infectious diseases among health care personnel.

详细描述

Influenza vaccination is given according to the normal routine of Hospital District of Helsinki and Uusimaa (HUS) occupational health care. Blood samples will be collected before vaccination, 5 weeks after vaccination and 6 months after vaccination. Both the same participants and also new participants will be recruited each year. The analysis will be mainly descriptive.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Members of health care or laboratory personnel in HUS having decided to take the seasonal influenza vaccination by the routine occupational health care service
  • General good health as established by or volunteer's own statement
  • Written informed consent
  • Presumably able and willing to participate in the study during the starting influenza season

排除标准

  • Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
  • Administration (longer than 14 days) of immunosuppressants or other immune- modifying drugs within 6 months before the vaccination; oral corticosteroids in dosages of 20 mg/day or more prednisolone or equivalent are excluded; inhaled or topical steroids are allowed.
  • Pregnancy or lactation
  • Acute disease at the time of enrolment (defined as the presence of a moderate or severe illness with or without fever)
  • Contraindication for influenza vaccination
  • Any other criteria which, in the investigator's or dedicated study staff member's opinion, would compromise the ability of a subject to participate in the study, a subject's well-being, or the outcome of the study

研究组 & 干预措施

Influenza vaccine recipients

Health care workers vaccinated by their occupational health care according to the routine praxis.

干预措施: influenza vaccine (Biological)

结局指标

主要结局

Humoral immunity against each present season's vaccine and circulating influenza strains

时间窗: 10 years

The presence and titer of antibodies against circulating influenza virus strains and vaccine strains of the current season from pre- and post-vaccination serum samples

次要结局

  • Cellular immunity against current and previous seasons' vaccine and circulating influenza strains(10 years)
  • Humoral immunity against previous seasons' vaccine and circulating influenza strains(10 years)
  • Effect of repeated vaccination against influenza(10 years)

研究者

发起方
Finnish Institute for Health and Welfare
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验